Australia turns to drug company representatives to cut prescribingBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7348.1234/a (Published 25 May 2002) Cite this as: BMJ 2002;324:1234
- Bob Burton
In a bid to cut the rising costs of government subsidised drugs—a rise partly caused by inappropriate prescribing—the Australian government has opted to enlist the sales force of pharmaceutical companies.
The decision has astonished consumer groups but been welcomed by its proponent, the Australian Pharmaceutical Manufacturers Association.
According to last week's Budget papers, savings will be achieved by ensuring that restrictions on the government's pharmaceutical benefits scheme, under which the government subsidises the costs of approved drugs, will be communicated to doctors through …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial